Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;6(1):107–165. doi: 10.1016/0165-2427(84)90050-3

The immunobiology of the feline leukemia virus

JL Rojko 1,2, RG Olsen 1,2
PMCID: PMC7119666  PMID: 6204435

The content is available as a PDF (3.1 MB).

References

  1. Ackerman G.A. Developmental relationship between the appearance of lymphocytes and lymphopoietic activity in the thymus and lymph nodes of the fetal cat. Anat. Rec. 1967;158:387–400. doi: 10.1002/ar.1091580404. [DOI] [PubMed] [Google Scholar]
  2. Anderson L.J., Jarrett W.F.H., Jarrett O., Laird H.M. Feline leukemia virus infection of kittens: Mortality associated with atrophy of the thymus and lymphoid depletion. J. Natl. Cancer Inst. 1971;47:807–817. [PubMed] [Google Scholar]
  3. Azocar J., Essex M. Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res. 1979;38:3388–3391. [PubMed] [Google Scholar]
  4. Barbacid M., Lauver A.V., Devare S.G. Biochemical and immunological characterization of polyproteins coded for by McDonough, Gardner-Arnstein and Snyder-Theilen strains of feline sarcoma virus. J. Virol. 1980;33:196–207. doi: 10.1128/jvi.33.1.196-207.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bartholomew R.M., Esser A.F. Differences in activation of human and guinea pig complement by retroviruses. J. Immunol. 1978;121:1748–1751. [PubMed] [Google Scholar]
  6. Benveniste R.E., Sherr C.J., Todaro G.J. Evolution of type C viral genes: Origin of feline leukemia virus. Science. 1975;190(4217):886–888. doi: 10.1126/science.52892. [DOI] [PubMed] [Google Scholar]
  7. Bishop J.M. Viral oncogenes: Curiosity or paradigm? Natl. Cancer Inst. Monograph. 1982;60:155–159. [PubMed] [Google Scholar]
  8. Bolognesi D.P., Montelaro R.C., Frank H., Schafer W. Assembly of type C oncornaviruses: A model. Science. 1978;199(4325):183–186. doi: 10.1126/science.202022. [DOI] [PubMed] [Google Scholar]
  9. Boyce J.T., Hoover E.A., Kociba G.J., Olsen R.G. Feline leukemia virus-induced erythroid aplasia: In vitro hemopoietic cultures studies. Exptl. Hematol. 1981;9:990–1001. [PubMed] [Google Scholar]
  10. Camitta B.M., Storb R., Thomas E.D. Aplastic anemia. I. Pathogenesis, diagnosis, treatment, and prognosis. New Engl. J. Med. 1982;306:645–652. doi: 10.1056/NEJM198203183061105. [DOI] [PubMed] [Google Scholar]
  11. Carlson J.H., Scott F.W., Duncan J.R. Feline panleukopenia. III. Development of lesions in the lymphoid tissues. Vet. Pathol. 1978;15:383–392. doi: 10.1177/030098587801500314. [DOI] [PubMed] [Google Scholar]
  12. Casey J.W., Roach A., Mullins J.I., Burck K.B.J., Nicolson M.O., Gardner M.B., Davidson N. Vol. 78. 1981. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats; pp. 7778–7782. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cerny J., Stiller R.A. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response. J. Immunol. 1975;115:943–949. [PubMed] [Google Scholar]
  14. Chattopadhay, S.K., Cloyd, M.W., Linemeyer, D.L., Lander, M.R., Rands, E.R. and Lowy, D.R. Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas. Nature (London), 295: 25–31. [DOI] [PubMed]
  15. Cianciolo G.J., Hunter J., Silva J., Haskill J.S., Snyderman R. Inhibitors of monocyte responses to chemotaxins are present in human cancerous infusions and react with monoclonal antibodies to the pl5(E) structural protein of retroviruses. J. Clin. Invest. 1981;68:831–839. doi: 10.1172/JCI110338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cockerell G.L., Krakowka S., Hoover E.A. Characterization of feline T- and B-lymphocytes and identification of an experimentally induced T-cell neoplasm in the cat. J. Natl. Cancer Inst. 1976;57:907–913. doi: 10.1093/jnci/57.4.907. [DOI] [PubMed] [Google Scholar]
  17. Cockerell G.L., Hoover E.A., Krakowka S. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J. Natl. Cancer Inst. 1976;57:1095–1099. doi: 10.1093/jnci/57.5.1095. [DOI] [PubMed] [Google Scholar]
  18. Cockerell G.L., Hoover E.A. Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus infected cats. Cancer Res. 1976;37:3985–3989. [PubMed] [Google Scholar]
  19. Collett M.S., Erikson R.L. Vol. 75. 1978. Protein kinase activity associated with the avian sarcoma virus; pp. 2021–2024. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cooper G.M. Cellular transforming genes. Science. 1982;217:801–806. doi: 10.1126/science.6285471. [DOI] [PubMed] [Google Scholar]
  21. Copelan E., Rinehart J.J., Lewis M.G., Olsen R.G., Sagone A. The mechanism of feline leukemia virus suppression of human T cell proliferation in vitro. J. Immunol. 1983 in press. [PubMed] [Google Scholar]
  22. Cotter S.M., Hardy W.D., Jr., Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J. Am. Vet. Med. Assoc. 1975;166:449–454. [PubMed] [Google Scholar]
  23. Cotter S.M., Essex M., McLane M.F., Grant C.K., Hardy W.D., Jr. Chemotherapy and passive immunotherapy in naturally occurring feline mediastinal lymphoma. Devel. in Cancer Res. 1980;4:219–226. [Google Scholar]
  24. Cowan K.M. Antibody response to viral antigens. Adv. in Immunol. 1973;17:195–253. doi: 10.1016/s0065-2776(08)60733-6. [DOI] [PubMed] [Google Scholar]
  25. Crawford T.B., Cheevers W.P., Klevjer-Anterson P. In: Persistent Viruses. Stevens J.G., editor. Academic Press; New York: 1978. p. 727. [Google Scholar]
  26. Daughaday C.C., Brandt W.E., McCown J.M., Russell P.K. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: Trypsinsensitive virus receptors and trypsin-resistant immune complex receptors. Infect. Immun. 1981;32:469–473. doi: 10.1128/iai.32.2.469-473.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Day N.K., O'Reilly-Felice C., Hardy W.D., Jr., Good R.A., Witkin S.S. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats. J. Immunol. 1980;126:2363–2366. [PubMed] [Google Scholar]
  28. de Both N.J., Kwak E., Klootwijk-vanDijke E. Erythrocyte production and survival in Rauscher murine leukemia virus-infected BALB/c mice. Cancer Res. 1980;40:4270–4275. [PubMed] [Google Scholar]
  29. Denman A.M., Rager-Zisman B., Merigan T.C., Tyrrell D.A.G. Replication or inactivation of different viruses by human lymphocyte preparations. Infect. Immun. 1974;9:373–376. doi: 10.1128/iai.9.2.373-376.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. de Noronha F., Schafer W., Essex M., Bolognesi D.P. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus. Virology. 1978;85:617–621. doi: 10.1016/0042-6822(78)90467-1. [DOI] [PubMed] [Google Scholar]
  31. Dubey J.P., Staunton D., Axocar J., Stux S., Essex M., Ynis E.J. Natural killer activity against retrovirus infected cells: Dichotomy in NK sensitivity of infected T & B cells. Clin. Immunol. and Immunopath. 1982;23:215–223. doi: 10.1016/0090-1229(82)90109-x. [DOI] [PubMed] [Google Scholar]
  32. Dunlap J.E., Nichols W.S., Hebebrand L.C., Mathes L.E., Olsen R.G. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines. Cancer Res. 1979;39:956–959. [PubMed] [Google Scholar]
  33. Dunn C.Y., Aaronson S.A., Stephenson J.R. Interactions of chemical inducers and steroid enhancers of endogenous mouse type-C RNA viruses. Virology. 1975;66:579–588. doi: 10.1016/0042-6822(75)90230-5. [DOI] [PubMed] [Google Scholar]
  34. Elder J., Gautsch J.W., Jensen F.C., Lerner R.A., Hartley J.W., Rowe W.P. Vol. 74. 1977. Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants; pp. 4676–4680. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Elder J., Mullins J.I. Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine MCF virus. J. Virol. 1983;46:871–880. doi: 10.1128/jvi.46.3.871-880.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Epstein M.A., Achong B.G. Recent progress in Epstein-Barr virus research. Ann. Rev. Microbiol. 1977;31:421–425. doi: 10.1146/annurev.mi.31.100177.002225. [DOI] [PubMed] [Google Scholar]
  37. Epstein R.S., Lopez D.M., Sigel M.M. Divergent appearance of complement receptors and Fc receptors on T cells in a murine mammary tumor system. Cell Immunol. 1978;40:154–163. doi: 10.1016/0008-8749(78)90323-4. [DOI] [PubMed] [Google Scholar]
  38. Essex M., Klein G., Snyder S.P., Harrold J.B. Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats. Intern. J. Cancer. 1971;8:384–390. doi: 10.1002/ijc.2910080305. [DOI] [PubMed] [Google Scholar]
  39. Essex M., Klein G., Snyder S.P., Harrold J.B. Feline sarcoma virus-induced tumors: Correlation between humoral antibody and tumor regression. Nature. 1971;233:195–197. doi: 10.1038/233195a0. [DOI] [PubMed] [Google Scholar]
  40. Essex M., Klein G., Deinhardt F., Wolfe L.G., Hardy W.D., Jr., Theilen G.H., Pearson L.D. Induction of the feline oncornavirus associated cell membrane antigen in human cells. Nature (New Biol.) 1972;238:187–189. doi: 10.1038/newbio238187b0. [DOI] [PubMed] [Google Scholar]
  41. Essex M., Hardy W.E., Cotter S.M., Jakowski R.M., Sliski A. Naturally occurring persistent feline oncornavirus infections in the absence of disease. Infect. Immun. 1975;11:470–475. doi: 10.1128/iai.11.3.470-475.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Essex M., Sliski A., Cotter S.M., Jakowski R.M., Hardy W.D., Jr. Immunosurveillance of naturally occurring feline leukemia. Science. 1975;190:790–792. doi: 10.1126/science.173019. [DOI] [PubMed] [Google Scholar]
  43. Fenner F. Summary of results of meetings of the International Committee on Taxonomy of Viruses in Madrid. Vol. 6. 1975–1976. The classification and nomenclature of viruses; pp. 1–12. (Intervirology). 1. [DOI] [PubMed] [Google Scholar]
  44. Fischinger P.J., Blevins C.S., Nomura S. Simple quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J. Virol. 1974;14:177–179. doi: 10.1128/jvi.14.1.177-179.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Fleissner E., Snyder H.W., Jr. Oncoviral proteins as cellular antigens. Curr. Top. Microbiol. Immunol. 1982;98:38–80. doi: 10.1007/978-3-642-68369-5_5. 1982. [DOI] [PubMed] [Google Scholar]
  46. Franchini G., Even J., Sherr C.J., Wong-Staal F. Onc sequences (v-fes) of Snyder-Theilen feline sarcoma virus are derived from noncontiguous regions of a cat cellular gene (c-fes) Nature (London) 1981;290:154–158. doi: 10.1038/290154a0. [DOI] [PubMed] [Google Scholar]
  47. Francis D.P., Essex M., Hardy W.D., Jr. Excretion of feline leukemia virus by naturally infected pet cats. Nature (London) 1977;269:252–254. doi: 10.1038/269252a0. [DOI] [PubMed] [Google Scholar]
  48. Gardner M.B., Rongey R.W., Arnstein P., Estes J.D., Sarma P., Huebner R.J., Rickard C.G. Experimental transmission of feline fibrosarcoma to cats and dogs. Nature (London) 1970;226:807–809. doi: 10.1038/226807a0. [DOI] [PubMed] [Google Scholar]
  49. Gilden R.V., Rabin H. Mechanisms of viral tumorigenesis. Adv. Virus Research. 1982;27:281–325. doi: 10.1016/s0065-3527(08)60437-6. [DOI] [PubMed] [Google Scholar]
  50. Gillette R.W., Fox A. Changes with age in homing properties and mitogen responses of lymphocytes from normal and leukemia prone mice. Cell Immunol. 1980;51:32–41. doi: 10.1016/0008-8749(80)90235-x. [DOI] [PubMed] [Google Scholar]
  51. Goodwin J.S., Webb D.R. Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol. 1980;15:106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  52. Gotoh Y.I., Sugamura K., Hinuma Y. Vol. 79. 1982. Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): Demonstration by clonal culture of ATLV-carrying T-cells from peripheral blood; pp. 4780–4782. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Grant C.K., DeBoer D.J., Essex M., Worley M.B., Higgins J. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement. J. Immunol. 1977;119:401–406. [PubMed] [Google Scholar]
  54. Grant C.K., de Noronha F., Tusch C., Michalek M.T., McLane M.F. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells. J. Natl. Cancer Inst. 1980;65:1285–1292. [PubMed] [Google Scholar]
  55. Grant C.K., Harris D., Essex M.E., Pickard D.K., Hardy W.D., Jr., de Noronha F. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody. J. Natl. Cancer Inst. 1980;64:1527–1533. doi: 10.1093/jnci/64.6.1527. [DOI] [PubMed] [Google Scholar]
  56. Grant C.K., Michalek M.T. Feline leukemia — Unique and cross-reacting antigens on individual virus-producing tumors identified by complement-dependent antibody. Intern. J. Cancer. 1981;28:209–217. doi: 10.1002/ijc.2910280215. [DOI] [PubMed] [Google Scholar]
  57. Gupta P., Ferrer J. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science. 1982;215:405–407. doi: 10.1126/science.6276975. [DOI] [PubMed] [Google Scholar]
  58. Haas M. Genetic analysis of in vitro leukemogenesis induced by thymus epithelial reticulum cells transmitting murine leukemia virus. Int. J. Cancer. 1978;21:115–120. doi: 10.1002/ijc.2910210119. [DOI] [PubMed] [Google Scholar]
  59. Haberman A., Velicer L.F. An oncornavirus with envelope properties of both FeLV and RD-114. Devel. in Cancer Res. 1980;4:517–530. [Google Scholar]
  60. Hampe A., Laprevotte I., Galibert F., Fedele L.A., Sherr C.J. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell. 1982;30:775–785. doi: 10.1016/0092-8674(82)90282-3. [DOI] [PubMed] [Google Scholar]
  61. Hankins W.D. Increased erythropoietin sensitivity after in vitro transformation of hematopoietic precursors by RNA tumor viruses. J. Natl. Cancer Inst. 1983;70:725–734. [PubMed] [Google Scholar]
  62. Hanna M.G., Jr., Szakal A.K., Tyndall R.L. Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue: Histological and ultrastructural studies of germinal centers and their relation to leukemogenesis. Cancer Res. 1970;30:1748–1763. [PubMed] [Google Scholar]
  63. Hardy W.D., Jr., Old L.J., Hess P.W., Essex M., Cotter S.M. Horizontal transmission of feline leukemia virus. Nature (London) 1973;244:266–269. doi: 10.1038/244266a0. [DOI] [PubMed] [Google Scholar]
  64. Hardy W.D., Jr., Hirshaut Y., Hess P.W. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibl. Haemat. 1973;39:778–799. doi: 10.1159/000427906. [DOI] [PubMed] [Google Scholar]
  65. Hardy W.D., Jr., Hess P.W., MacEwen E.G., McClelland A.J., Zuckerman E.E., Essex M., Cotter S.M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res. 1976;36:582–588. [PubMed] [Google Scholar]
  66. Hardy W.D., Jr., Zuckerman E.E., MacEwen E.G., Hayes A.A., Essex M. A feline leukemia and sarcoma virus-induced tumor specific antigen. Nature. 1977;270:249–251. doi: 10.1038/270249a0. [DOI] [PubMed] [Google Scholar]
  67. Hardy W.D., Jr., McClelland A.J., Zuckerman E.E., Snyder H.W., Jr., MacEwen E.G., Francis D., Essex M. Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV. Nature (London) 1980;288:90–92. doi: 10.1038/288090a0. [DOI] [PubMed] [Google Scholar]
  68. Hayward W.S., Neel B.G., Astrin S.M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (London) 1981;290:475–480. doi: 10.1038/290475a0. [DOI] [PubMed] [Google Scholar]
  69. Hebebrand L.C., Olsen R.G., Mathes L.E., Nichols W.S. Inhibition of a human lymphocyte mitogen and antigen response by a 15,000 dalton protein from feline leukemia virus. Cancer Res. 1979;39:443–447. [PubMed] [Google Scholar]
  70. Heding L.D., Schaller J.P., Blakeslee J.B., Olsen R.G. Inactivation of tumor cell-associated feline oncornavirus for preparation of an infectious virus-free tumor cell immunogen. Cancer Res. 1976;36:1647–1652. [PubMed] [Google Scholar]
  71. Herberman R.B., editor. NK cells and other natural effector cells. Academic Press; New York: 1982. pp. 1–1566. [Google Scholar]
  72. Hoover E.A., McCullough B., Griesemer R.A. Intranasal transmission of feline leukemia. J. Natl. Cancer Inst. 1972;59:973–983. [PubMed] [Google Scholar]
  73. Hoover E.A., Perryman L.E., Kociba G.J. Early lesions in cats inoculated with feline leukemia virus. Cancer Res. 1973;33:145–152. [PubMed] [Google Scholar]
  74. Hoover E.A., Kociba G.J., Hardy W.D., Yohn D.S. Erythroid hyperplasia in cats inoculated with feline leukemia virus. J. Natl. Cancer Inst. 1974;53:1271–1276. doi: 10.1093/jnci/53.5.1271. [DOI] [PubMed] [Google Scholar]
  75. Hoover E.A., Olsen R.G., Hardy W.D., Jr., Schaller J.P., Mathes L.E. Feline leukemia virus infection: Age-related variation in response of cats to experimental infection. J. Natl. Cancer Inst. 1976;57:365–369. doi: 10.1093/jnci/57.2.365. [DOI] [PubMed] [Google Scholar]
  76. Hoover E.A., Olsen R.G., Mathes L.E., Schaller J.P. Relationship between feline leukemia virus antigen expression in blood and bone marrow and viral infectivity in blood, bone marrow, and saliva of cats. Cancer Res. 1977;37:3707–3710. [PubMed] [Google Scholar]
  77. Hoover E.A., Schaller J.P., Mathes L.E., Olsen R.G. Passive immunity to feline leukemia: Evaluation of immunity from dams naturally infected and experimentally vaccinated. Infect. Immun. 1977;16:49–54. doi: 10.1128/iai.16.1.54-59.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Hoover E.A., Krakowka S., Cockerell G.L., Mathes L.E., Olsen R.G. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma. Am. J. Vet. Res. 1978;39:393–395. [PubMed] [Google Scholar]
  79. Hoover E.A., Rojko J.L., Wilson P.L., Olsen R.G. Determinants of susceptibility and resistance to feline leukemia virus. I. Role of macrophages. J. Natl. Cancer Inst. 1981;67:889–898. doi: 10.1093/jnci/67.4.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hoover E.A., Rojko J.L., Quackenbush S.L. Congenital feline leukemia virus infection. Comp. Leuk. Res. 1983;11:7–8. [Google Scholar]
  81. Huddlestone J.R., Lampert P.W., Oldstone M.B.A. Virus-lymphocyte interactions: Infection of TG and TM subsets by measles virus. Clinical Immunol. Immunopathol. 1980;15:502–509. doi: 10.1016/0090-1229(80)90062-8. [DOI] [PubMed] [Google Scholar]
  82. Hughes S.H., Shank P.R., Spector D.H., Kung H.J., Bishop J.M., Varmus H.E., Vogt P.K., Breitman M.L. Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and intergrated at many sites. Cell. 1978;15:1397–1410. doi: 10.1016/0092-8674(78)90064-8. [DOI] [PubMed] [Google Scholar]
  83. Ihle J.N., Lee J.C., Rebar L. T-cell recognition of Moloney leukemia virus proteins. III. T-cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid hydrogenase in splenic lymphocytes. J. Immunol. 1981;127:2565–2570. [PubMed] [Google Scholar]
  84. Ikeda, H. and Wright, M.J. Chromatographic separation and antigenic analyses proteins of the oncornaviruses. V. Identification of a new murine viral protein p15(E). J. Virology, 16: 53–61. [DOI] [PMC free article] [PubMed]
  85. Isaak D., Cerny J. T and B lymphocyte susceptibility to murine leukemia virus moloney. Infect. Immun. 1983;40:977–984. doi: 10.1128/iai.40.3.977-984.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Isaak D.D., Price J.A., Reinish C.L., Cerny J. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph node. J. Immunol. 1979;123:1822–1828. [PubMed] [Google Scholar]
  87. Jacquemin P.C., Saxinger C., Gallo R.C. Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type-C viral reverse transcriptases. Nature. 1978;276:230–236. doi: 10.1038/276230a0. [DOI] [PubMed] [Google Scholar]
  88. Jakowski R.M., Essex M., Hardy W.D., Jr., Stephenson J.R., Cotter S.M. Membranous glomerulonephritis is a household cluster of cats persistently viremic with feline leukemia virus. Devel. Cancer Res. 1980;4:141–150. [Google Scholar]
  89. Jarrett O., Russell P.H. Differential growth and transmission in cats of feline leukemia viruses of subgroups A and B. Intern. J. Cancer. 1978;21:466–472. doi: 10.1002/ijc.2910210411. [DOI] [PubMed] [Google Scholar]
  90. Jarrett, O., Golder, M.C. and Weijer, K., 1983. Personal communication.
  91. Jarrett W., Anderson L.J., Jarrett O., Laird H.M., Stewart M.F. Myeloid leukaemia in a cat produced experimentally by feline leukaemia virus. Res. Vet. Sci. 1971;12:385–387. [PubMed] [Google Scholar]
  92. Jarrett W., Jarrett O., Mackey L., Laird H.M., Hardy W.D., Jrs., Essex M. Horizontal transmission of leukemia virus and leukemia in the cat. J. Natl. Cancer Inst. 1973;51:833–841. doi: 10.1093/jnci/51.3.833. [DOI] [PubMed] [Google Scholar]
  93. Jones F.R., Yoshida L.H., Ladiges W.C., Kenny M.A. Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG: A preliminary report. Cancer. 1980;46:675–684. doi: 10.1002/1097-0142(19800815)46:4<675::aid-cncr2820460408>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  94. Kobilinsky L., Hardy W.D., Jr., Ellis R., Day N.K. Vol. 38. 1979. Activation of feline complement by feline leukemia virus; pp. 1089–1096. (Fed. Proc.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Kociba, G.J. and Wellman, M., 1983. Manuscript in preparation.
  96. Koshy R., Gallo R.C., Wong-Staal F. Characterization of the endogenous feline leukemia virus-related DNA sequences in tissues of virus negative leukemic animals. Virology. 1980;103(2):434–445. doi: 10.1016/0042-6822(80)90202-0. [DOI] [PubMed] [Google Scholar]
  97. Lee F., Mulligan R., Berg P., Ringold G. Glucocorticosteroids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumor virus chimaeric plasmids. Nature (London) 1981;294:228–232. doi: 10.1038/294228a0. [DOI] [PubMed] [Google Scholar]
  98. Lee J.C., Ihle J.N. Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas. Nature (London) 1981;289:407–409. doi: 10.1038/289407a0. [DOI] [PubMed] [Google Scholar]
  99. Lee J.C., Ihle J.N. Mechanisms of C-type viral leukomogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia. J. Immunol. 1979;123:2351–2358. [PubMed] [Google Scholar]
  100. Lewis M.G., Olsen R.G. Nature. 1983 submitted. [Google Scholar]
  101. Lewis M.G., Fertel R.H., Olsen R.G. Nature. 1983 submitted. [Google Scholar]
  102. Lewis M.G., Kociba G.J., Rojko J.L., Olsen R.G. J. Natl. Cancer Inst. 1983 submitted. [Google Scholar]
  103. Litvak S., Araya A. Primer transfer RNA in retroviruses. Trends in Biochem. Sci. 1982;7:361–364. [Google Scholar]
  104. Lutz H., Pedersen N., Higgins J., Hubscher U., Troy F.A., Theilen G.H. Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus. Cancer Res. 1980;40:3642–3651. [PubMed] [Google Scholar]
  105. Mackey L.J., Jarrett W., Jarrett O., Laird H. Anemia associated with feline leukemia virus infection in cats. J. Natl. Cancer Inst. 1975;54:1–5. doi: 10.1093/jnci/54.1.209. [DOI] [PubMed] [Google Scholar]
  106. Madewell B.L., Jarrett O. Recovery of feline leukaemia virus from non-viraemic cats. Vet. Rec. 1983;112:339–342. doi: 10.1136/vr.112.15.339. [DOI] [PubMed] [Google Scholar]
  107. Marcelletti J., Furmanski P. Infection of macrophages with Friend virus: Relationship to the spontaneous regression of viral erythroleukemia. Cell. 1979;16:649–659. doi: 10.1016/0092-8674(79)90038-2. [DOI] [PubMed] [Google Scholar]
  108. Mathes L.E., Yohn D.S., Hoover E.A., Essex M., Schaller J.P., Olsen R.G. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus. J. Natl. Cancer Inst. 1976;56:1197–1200. doi: 10.1093/jnci/56.6.1197. [DOI] [PubMed] [Google Scholar]
  109. Mathes L.E., Olsen R.G., Hebebrand L.C., Hoover E.A., Schaller J.P. Abrogation of lymphocyte blastogenesis by a feline leukemia virus protein. Nature. 1978;274:687–689. doi: 10.1038/274687a0. [DOI] [PubMed] [Google Scholar]
  110. Mathes L.E., Olsen R.G. Feline Leukemia. CRC Press; Boca Raton, FL: 1981. Immunobiology of feline leukemia virus disease; pp. 77–88. [Google Scholar]
  111. McAllister R.M., Nicolson M.O., Gardner M.B., Rongey R.W., Rasheed S., Sarma P.S. C-type virus released from cultured human habdomyosarcoma cells. Nature (New Biol.) 1972;235:3–6. doi: 10.1038/newbio235003a0. [DOI] [PubMed] [Google Scholar]
  112. McCarty J., Grant C.K. Cell Immunol. 1983 doi: 10.1016/0008-8749(83)90221-6. in press. [DOI] [PubMed] [Google Scholar]
  113. McGrath, M.S., Decleve, A., Lieberman, M., Kaplan, H.S. and Weissman, I.L. Specificity of cell surface virus receptors on radiation leukemia virus and radiation-induced thymic lymphomas. J. Virol., 28: 819–829. [DOI] [PMC free article] [PubMed]
  114. Miyoshi, I., Kubonishi, S., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagatak, K. and Hinuma, Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T-cells. Nature (London), 394: 770–771. [DOI] [PubMed]
  115. Mogensen S.C. Role of macrophages in natural resistance to virus infections. Microbiol. Rev. 1979;43:1–26. doi: 10.1128/mr.43.1.1-26.1979. 1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Mullins J.I., Casey J.W., Nicolson M.O., Burck K.B.J., Davidson N. Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line. J. Virol. 1981;38(2):688–703. doi: 10.1128/jvi.38.2.688-703.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Narayan O., Griffin D.E., Chase J. Antigenic shift of visna virus in persistently infected sheep. Science. 1977;197:376–378. doi: 10.1126/science.195339. [DOI] [PubMed] [Google Scholar]
  118. Neel B.G., Hayward W.S., Robinson H.L., Fang J., Astrin S.M. Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: Oncogenesis by promoter insertion. Cell. 1981;23(2):323–334. doi: 10.1016/0092-8674(81)90128-8. [DOI] [PubMed] [Google Scholar]
  119. Niman H.L., Akhari M., Gardner M.B., Stephenson J.R., Roy-Burman P. RD-114 and feline leukaemia virus genome expression in natural lymphomas of domestic cats. Nature (London) 1977;266:357–360. doi: 10.1038/266357a0. [DOI] [PubMed] [Google Scholar]
  120. Niman H.L., Gardner M.B., Stephenson J.R., Roy-Burman P. Endogenous RD-114 virus genome expression in malignant tissues of domestic cats. J. Virol. 1977;23:578–586. doi: 10.1128/jvi.23.3.578-586.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Nowinski R.C., Hays E.F., Doyle T., Linkhart S., Medeiro S.E., Pickering R. Oncornaviruses produced by murine leukemia cells in culture. Virology. 1977;81:363–370. doi: 10.1016/0042-6822(77)90152-0. [DOI] [PubMed] [Google Scholar]
  122. Okabe H., duBuy J., Gilden R.V., Gardner M.B. A portion of the feline leukaemia virus genome is not endogenous in cat cells. Intern. J. Cancer. 1978;22:70–78. doi: 10.1002/ijc.2910220114. [DOI] [PubMed] [Google Scholar]
  123. Okasinki G.F., Velicer L.F. Analysis of intracellular feline leukemia virus proteins. II. The generation of FeLV structural proteins from precursor polypeptides. J. Virol. 1977;22:74–85. doi: 10.1128/jvi.22.1.74-85.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Onions D., Testa N., Jarrett O. Growth of FeLV in haemopoietic cells in vitro. Develop. Cancer Res. 1980;4:513–516. [Google Scholar]
  125. Onions D., Jarrett O., Testa N., Frassoni F., Toth S. Selective effect of feline leukemia virus on early erythroid precursors. Nature. 1982;296:156–158. doi: 10.1038/296156a0. [DOI] [PubMed] [Google Scholar]
  126. Pedersen, N.C., Theilen, G., Keane, M.A., Fairbanks, L., Mason, T., Orser, B., Chen, C.H. and Allison, C. Studies of naturally transmitted feline leukemia virus infection. Am. J. Vet. Res., 38: 1523–1531. [PubMed]
  127. Peiris J.S.M., Gordon S., Unkeless J.C., Porterfield J.S. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981;289:189–191. doi: 10.1038/289189a0. [DOI] [PubMed] [Google Scholar]
  128. Perryman, L.E., Hoover, E.A. and Yohn, D.S. Immunologic reactivity of the cat: Immunosuppression in experimental feline leukemia. J. Natl. Cancer Inst., 49: 1365–1397. [PubMed]
  129. Pinter A., Fleissner E. Structural studies of retroviruses: Characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J. Virol. 1979;30:157–165. doi: 10.1128/jvi.30.1.157-165.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Piper, C.E., Ferrer, J.F., Abt, D.A. and Marshak, R.R. Postnatal and prenatal transmission of the bovine leukemia virus under natural conditions. J. Natl. Cancer Inst., 62: 165–168. [PubMed]
  131. Poiesz B., Ruscetti F.W., Reitz M.S., Kalyanaraman V.S., Gallo R.C. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature. 1981;294:268–271. doi: 10.1038/294268a0. [DOI] [PubMed] [Google Scholar]
  132. Popovic M., Kalyanaraman V.S., Sarngadharan M.G., Robert-Guroff M., Nakgo Y., Reitz M.S., Miyoshi Y., Ito Y., Minowada J., Gallo R.C. The virus of Japanese adult T-cell leukemia is a member of the human T-cell leukemia virus group. Nature (London) 1982;300:63–66. doi: 10.1038/300063a0. [DOI] [PubMed] [Google Scholar]
  133. Post J.E., Warren L. Reactivation of latent feline leukemia virus. Developments in Cancer Res. (Feline Leukemia Virus) 1980:151–158. [Google Scholar]
  134. Profitt M.R., editor. Virus Lymphocyte Interactions: Implications for Disease. Elsevier, North Nolland; New York: 1979. pp. 1–183. [Google Scholar]
  135. Rice J.B., Olsen R.G. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group specific antigen expression in bone marrow and serum. J. Natl. Cancer Inst. 1981;66:737–743. [PubMed] [Google Scholar]
  136. Rice J.B., Schaller J.P., Lewis M.G., Mathes L.E., Hoover E.A., Olsen R.G. Infection of feline embryo adherent cells with feline leukemia virus: Feline oncornavirus-associated cell membrane antigen expression and morphologic transformation. J. Natl. Cancer Inst. 1981;66:89–96. [PubMed] [Google Scholar]
  137. Rojko J.L., Hoover E.A., Mathes L.E., Schaller J.P., Olsen R.G. Pathogenesis of experimental feline leukemia virus infection. J. Natl. Cancer Inst. 1979;63:759–778. doi: 10.1093/jnci/63.3.759. [DOI] [PubMed] [Google Scholar]
  138. Rojko J.L., Hoover E.A., Mathes L.E., Krakowka S., Olsen R.G. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Cancer Res. 1979;39(9):3789–3791. [PubMed] [Google Scholar]
  139. Rojko J.L., Hoover E.A., Finn B.L., Olsen R.G. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibillity of feline lymphocytes to productive feline leukemia infection. J. Natl. Cancer Inst. 1981;67:899–910. [PubMed] [Google Scholar]
  140. Rojko J.L., Hoover E.A., Quackenbush S.L., Olsen R.G. Reactivation of latent feline leukaemia virus infection. Nature. 1982;298:385–388. doi: 10.1038/298385a0. [DOI] [PubMed] [Google Scholar]
  141. Rojko J.L., Hoover E.A., Finn B.L., Olsen R.G. Characterization and mitogenesis of feline lymphocyte populations. Int. Arch. Allergy Appl. Immunol. 1982;68:226–232. doi: 10.1159/000233103. [DOI] [PubMed] [Google Scholar]
  142. Rojko, J.L., Cheney, C.M., Kociba, G.J. and Olsen, R.G. Infectious feline leukemia virus depresses erythrogenesis in vitro. Comp. Leuk. Res., 11: 129–130.
  143. Rojko, J.L., Stiff, M.I., Wilson, P.L., and Rojko, P.D., 1983. Unpublished data.
  144. Rosenberg Z., Crowther R.L., Essex M., Jarrett O., Haseltine W.A. Isolation via transfection of feline leukemia viruses from DNA of naturally occurring feline lymphomas. Virol. 1981;115:203–210. doi: 10.1016/0042-6822(81)90102-1. [DOI] [PubMed] [Google Scholar]
  145. Rouse B.T., Babiak L.A. Mechanisms of recovery from herpesvirus infections — A review. Can. J. Comp. Med. 1978;42:414–427. [PMC free article] [PubMed] [Google Scholar]
  146. Ruddle N.H., Armstrong M.Y.K., Richards F.F. Vol. 73. 1976. Replication of murine leukemia virus in bone marrow derived lymphocytes; pp. 3714–3718. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Russell P.H., Jarrett O. The specificity of neutralizing antibodies to feline leukemia viruses. Intern. J. Cancer. 1978;21:768–778. doi: 10.1002/ijc.2910210615. [DOI] [PubMed] [Google Scholar]
  148. Sarma P.S., Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology. 1973;54:160–169. doi: 10.1016/0042-6822(73)90125-6. [DOI] [PubMed] [Google Scholar]
  149. Saxinger C., Essex M., Hardy W., Gallo R. Detection of antigen related to feline leukemia virus in the sera of “virus-negative” cats. Developments in Cancer Research (Feline Leukemia Virus) 1980;4:489–496. [Google Scholar]
  150. Schachat D.A., Fefer A., Moloney J.B. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney) Cancer Res. 1968;28:517–520. [PubMed] [Google Scholar]
  151. Schafer W., Bolognesi D.P. Mammalian C-type oncornaviruses: Relationships between viral structure and cell surface antigens and their possible significance in immunological defense mechanisms. Contemp. Top. Immunobiol. 1977;6:127–167. doi: 10.1007/978-1-4684-3051-6_4. [DOI] [PubMed] [Google Scholar]
  152. Schaller J.P., Olsen R.G. Determination of subgroup-specific feline oncornavirus neutralizing antibody. Infect. Immun. 1975;12:1405–1410. doi: 10.1128/iai.12.6.1405-1410.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Schaller J.P., Hoover E.A., Olsen R.G. Active and passive immunization of cats with inactivated feline oncornaviruses. J. Natl. Cancer Inst. 1977;59:1441–1450. doi: 10.1093/jnci/59.5.1441. [DOI] [PubMed] [Google Scholar]
  154. Schaller J.P., Mathes L.E., Hoover E.A., Koestner A., Olsen R.G. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea. Cancer Res. 1978;38:996–998. [PubMed] [Google Scholar]
  155. Schlesinger J.J., Brandriss M.W. Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus. J. Med. Virol. 1981;8:103–117. doi: 10.1002/jmv.1890080204. [DOI] [PubMed] [Google Scholar]
  156. Schultz R.M., Chirigos M.A., Stoychkov J.N., Pavlidis N.A. Factors affecting macrophage cytotoxic activity with particular emphasis on corticosteroids and acute stress. J. Reticuloendothelial Soc. 1979;126(1):83–92. [PubMed] [Google Scholar]
  157. Schwarz H., Fischinger P.J., Ihle J.N., Thiel H.J., Weiland F., Bolognesi D.P., Schafer W. Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fatal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp71. Virology. 1979;93:159–174. doi: 10.1016/0042-6822(79)90284-8. [DOI] [PubMed] [Google Scholar]
  158. Scolnik E., Rands E., Aaronson S.A., Todaro G. Vol. 67. 1970. RNA-dependent DNA polymerase activity in five RNA viruses: Divalent cation requirements; pp. 1789–1796. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Sherwin S., Benveniste R., Todaro G. Complement-mediated lysis of type C viruses: Effect of primate and human sera on various retroviruses. Intern. J. Cancer. 1978;21:6–11. doi: 10.1002/ijc.2910210103. [DOI] [PubMed] [Google Scholar]
  160. Sliski A.H., Essex M., Meyer C., Todaro G. Feline oncornavirus-associated cell membrane antigen: Expression in transformed nonproducer mink cells. Science. 1977;196:1336–1339. doi: 10.1126/science.194310. [DOI] [PubMed] [Google Scholar]
  161. Snyder H.W., Jones F.R., Day N.K., Hardy W.D., Jr. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption. J. Immunol. 1982;124:2726–2730. [PubMed] [Google Scholar]
  162. Snyder S.P., Theilen G.H. Transmissible feline fibrosarcoma. Nature (London) 1969;221:1074. doi: 10.1038/2211074a0. [DOI] [PubMed] [Google Scholar]
  163. Soe L.H., Devi B.G., Mullins J.I., Roy-Burman P. Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library. J. Virol. 1983;46:829–840. doi: 10.1128/jvi.46.3.829-840.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Stephenson J.R., Essex M., Hino S., Hardy W.D., Jr., Aaronson S.A. Vol. 54. 1977. Feline oncornavirus-associated cell membrane antigen (FOCMA): Distinction between FOCMA and the major virion glycoprotein; pp. 1219–1223. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Stiff M.I., Olsen R.G. Loss of the short-lived suppressive funciton of peripheral-infected cats. J. Clin. Lab. Immunol. 1982;7:133–138. [PubMed] [Google Scholar]
  166. Stiff M.I., Olsen R.G. Effects of retrovirus protein on the feline one way mixed leukocyte reaction. J. Gen. Virol. 1983;64:957–959. doi: 10.1099/0022-1317-64-4-957. [DOI] [PubMed] [Google Scholar]
  167. Tarr M.J., Olsen R.G., Hoover E.A., Kociba G.J., Schaller J.P. The effects of methylnitrosourea on the immune system and hematopoietic system of adult specific pathogen free cats. Chem. Biol. Interact. 1979;28:181–189. doi: 10.1016/0009-2797(79)90160-1. [DOI] [PubMed] [Google Scholar]
  168. Taylor P., Hokama Y., Perri S.F. Differentiating feline T and B lymphocytes by rosette formation. J. Immunol. 1975;115:862–865. [PubMed] [Google Scholar]
  169. Temin H.M. Mechanism of cell transformation by RNA tumor viruses. Ann. Rev. Micro. 1971;8:639–648. doi: 10.1146/annurev.mi.25.100171.003141. [DOI] [PubMed] [Google Scholar]
  170. Testa N.G., Onions D., Jarrett O., Frassoni F., Eliason J.F. Haemopoietic colony formation (BFU-E, GM-CFC) during the development of pure red cell hypoplasia induced in the cat by felline leukaemia virus. Leuk. Res. 1983;7:103–116. doi: 10.1016/0145-2126(83)90001-2. [DOI] [PubMed] [Google Scholar]
  171. Thorley-Lawson D.A. The suppression of Epstein-Barr virus infection occurs after infection but before transformation of the cell. J. Immunol. 1980;124:745–751. [PubMed] [Google Scholar]
  172. Till J.E., McCulloch E.A., Siminovitch L. Vol. 51. 1964. A stochastic model of stem cell proliferation based on the growth of spleen colony-forming cells; pp. 29–36. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Tompkins M.B., Cummins J.M. Response of feline leukemia virus-induced nonregenerative anemia to oral administration of an interferon-containing preparation. Fel Pract. 1982;12:6–15. [Google Scholar]
  174. Trainin Z., Wernicke D., Ungar-Waron H., Essex M. Suppression of the humoral antibody response in natural retrovirus infections. Science. 1983;220:858–859. doi: 10.1126/science.6302837. [DOI] [PubMed] [Google Scholar]
  175. Tsichlis P.N., Strauss P.G., Hu L.F. A common region for proviral DNA integration in MoMuLV-induced rat thymic lymphomas. Nature. 1983;302:445–449. doi: 10.1038/302445a0. [DOI] [PubMed] [Google Scholar]
  176. Unanue E.R. Cooperation between mononuclear phagocytes and lymphocytes in immunity. N. Engl. J. Med. 1980;303:977–985. doi: 10.1056/NEJM198010233031706. [DOI] [PubMed] [Google Scholar]
  177. Varmus H.E. Form and function of retroviral proviruses. Science. 1982;216(4548):812–820. doi: 10.1126/science.6177038. [DOI] [PubMed] [Google Scholar]
  178. Vedbrat S.S., Rasheed S., Lutz H., Gonda M.A., Ruscetti S., Gardner M.B., Prensky W. Feline oncornavirus-associated cell membrane antigen: A viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Virology. 1983;124:445–461. doi: 10.1016/0042-6822(83)90360-4. [DOI] [PubMed] [Google Scholar]
  179. Veronese F., Kelloff G.J., Reynolds F.H., Jr., Hill R.W., Stephenson J.R. Monoclonal antibodies specific to transforming polyproteins encoded by independent isolates of feline sarcoma virus. J. Virol. 1982;43:896–904. doi: 10.1128/jvi.43.3.896-904.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Wainberg M.A., Vydelingum S., Margolese R.G. Viral inhibition of lymphocyte mitogenesis: Interference with the synthesis of functionally active T-cell growth factor (TCGF) activity and reversal of inhibition by the addition of same. J. Immun. 1983;130:2372–2378. [PubMed] [Google Scholar]
  181. Weiss R.A., Teich N., Varmus H.E., Coffin J.N., editors. The Molecular Biology of Tumor Viruses, Part III, RNA Tumor Viruses. Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1983. in press. [Google Scholar]
  182. Weller S.K., Joy A.E., Temin H.M. Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J. Virol. 1980;33:494–506. doi: 10.1128/jvi.33.1.494-506.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Welsh R.M., Cooper N.R., Jensen F.C., Oldstone M.B.A. Human serum lyses RNA-tumor viruses. Nature (London) 1975;257:612–614. doi: 10.1038/257612a0. [DOI] [PubMed] [Google Scholar]
  184. Yamamoto N., Okada M., Koyanagi Y., Kannagi M., Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T-cell leukemia virus producer cell line. Science. 1982;217:737–739. doi: 10.1126/science.6980467. [DOI] [PubMed] [Google Scholar]
  185. Yoshiki T., Mellors R.C., Hardy W.D., Jr. Common cell surface antigen expression associated with mammalian C-type RNA viruses. J. Exptl. Med. 1974;139:925–942. doi: 10.1084/jem.139.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Veterinary Immunology and Immunopathology are provided here courtesy of Elsevier

RESOURCES